This content first appeared upon GuruFocus.
People familiar with the matter stated BrainCo has in complete confidence filed for some sort of Hong Kong first public offering, the move that could position it since the first regarding China's so-called Hangzhou Six to reach public markets. According to those people, the particular company is working together with China International Funds Corp. and UBS Group AG (NYSE: UBS) on the potential listing, along with discussions ongoing plus a fundraising concentrate on that could reach several hundred thousand dollars. The men and women cautioned that discussions are continuing in addition to key terms, like the size of the offering, remain below review, while reps for BrainCo plus UBS declined in order to comment and CICC failed to respond to a request comment.
Brainco ! GuruFocus has detected 9 Warning Symptoms with INTC.
Is INTC fairly appreciated? Test your thesis with our free DCF calculator.
BrainCo's filing comes as investor attention more and more turns to Hangzhou's next-generation technology companies, a group of which also includes DeepSeek and operates away of the exact same city that will be home to Alibaba Group Holding Ltd. (NYSE: BABA) Typically the company is component of a larger wave of Chinese startups seeking to be able to contend with U. S. players such because Neuralink Corp. throughout brain-computer interface technologies, an area which includes emerged as the new front in the wider scientific rivalry between Beijing and Washington.
Founded in 2015 by simply Han Bicheng, BrainCo develops bionic hands or legs and non-invasive head technologies, setting it apart from implant-based approaches used simply by Neuralink. Shanghai Securities News reported last week that this firm completed a a couple of billion yuan ($287 million) financing rounded co-led by IDG Capital and Walden International, these founded by Intel Corp. (NASDAQ: INTC) Key Executive Officer Lip-Bu Tan. That foundation aligns with much wider industry momentum, while CCID Consulting Co. estimates China's brain-computer interface sector may grow at a good annual rate involving 20% in the approaching years, alongside developments by other national players such as Shanghai in china StairMed Technology and Shanghai NeuroXess Technology.